Literature DB >> 22840515

Homeodomain-interacting protein kinase regulates Hippo pathway-dependent tissue growth.

Carole L C Poon1, Xiaomeng Zhang, Jane I Lin, Samuel A Manning, Kieran F Harvey.   

Abstract

The Salvador-Warts-Hippo (SWH) pathway is an evolutionarily conserved regulator of tissue growth that is deregulated in human cancer. Upstream SWH pathway components convey signals from neighboring cells via a core kinase cassette to the transcription coactivator Yorkie (Yki). Yki controls tissue growth by modulating activity of transcription factors including Scalloped (Sd). To date, five SWH pathway kinases have been identified, but large-scale phosphoproteome studies suggest that unidentified SWH pathway kinases exist. To identify such kinases, we performed an RNA interference screen and isolated homeodomain-interacting protein kinase (Hipk). Unlike previously identified SWH pathway kinases, Hipk is unique in its ability to promote, rather than repress, Yki activity and does so in parallel to the Yki-repressive kinase, Warts (Wts). Hipk is required for basal Yki activity and is likely to regulate Yki function by promoting its accumulation in the nucleus. Like many SWH pathway proteins, Hipk's function is evolutionarily conserved as its closest human homolog, HIPK2, promotes activity of the Yki ortholog YAP in a kinase-dependent fashion. Further, HIPK2 promotes YAP abundance, suggesting that the mechanism by which HIPK2 regulates YAP has diverged in mammals.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22840515     DOI: 10.1016/j.cub.2012.06.075

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  38 in total

1.  Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer.

Authors:  Yi Qin; Qiangsheng Hu; Shunrong Ji; Jin Xu; Weixing Dai; Wensheng Liu; Wenyan Xu; Qiqing Sun; Zheng Zhang; Quanxing Ni; Xianjun Yu; Bo Zhang; Xiaowu Xu
Journal:  Cell Prolif       Date:  2019-04-01       Impact factor: 6.831

Review 2.  Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies.

Authors:  Min Hwan Kim; Joon Kim
Journal:  Cell Mol Life Sci       Date:  2016-11-08       Impact factor: 9.261

3.  Causes and consequences of genetic background effects illuminated by integrative genomic analysis.

Authors:  Christopher H Chandler; Sudarshan Chari; David Tack; Ian Dworkin
Journal:  Genetics       Date:  2014-02-05       Impact factor: 4.562

Review 4.  The Hippo signaling pathway in stem cell biology and cancer.

Authors:  Jung-Soon Mo; Hyun Woo Park; Kun-Liang Guan
Journal:  EMBO Rep       Date:  2014-05-12       Impact factor: 8.807

Review 5.  The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.

Authors:  Manami Kodaka; Yutaka Hata
Journal:  Cell Mol Life Sci       Date:  2014-09-30       Impact factor: 9.261

Review 6.  The hippo pathway provides novel insights into lung cancer and mesothelioma treatment.

Authors:  Xiao-Lan Liu; Rui Zuo; Wen-Bin Ou
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-03       Impact factor: 4.553

7.  The GTPase regulatory proteins Pix and Git control tissue growth via the Hippo pathway.

Authors:  Lucas G Dent; Carole L C Poon; Xiaomeng Zhang; Joffrey L Degoutin; Marla Tipping; Alexey Veraksa; Kieran F Harvey
Journal:  Curr Biol       Date:  2014-12-04       Impact factor: 10.834

8.  A Hippo-like Signaling Pathway Controls Tracheal Morphogenesis in Drosophila melanogaster.

Authors:  Carole L C Poon; Weijie Liu; Yanjun Song; Marta Gomez; Yavuz Kulaberoglu; Xiaomeng Zhang; Wenjian Xu; Alexey Veraksa; Alexander Hergovich; Amin Ghabrial; Kieran F Harvey
Journal:  Dev Cell       Date:  2018-10-25       Impact factor: 12.270

9.  Rox8 promotes microRNA-dependent yki messenger RNA decay.

Authors:  Xiaowei Guo; Yihao Sun; Taha Azad; H J Janse van Rensburg; Jingjing Luo; Shuai Yang; Peng Liu; Zhongwei Lv; Meixiao Zhan; Ligong Lu; Yingqun Zhou; Xianjue Ma; Xiaoping Zhang; Xiaolong Yang; Lei Xue
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-17       Impact factor: 11.205

Review 10.  Posttranslational modifications regulate HIPK2, a driver of proliferative diseases.

Authors:  Vera V Saul; M Lienhard Schmitz
Journal:  J Mol Med (Berl)       Date:  2013-04-25       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.